Arthritis Clinical Trials

Find Arthritis Clinical Trials Near You

The Self-management App 'MinUrinsyregikt' for Patients With Gout. The ReMonit Gout Feasibility Study in Primary Care

Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The goal of this feasibility study is to determine the feasibility of a patient self-management app (MinUrinsyregikt) for patients with gout. The primary objectives of the study are: 1. To determine the feasibility of a patient self-management app for patients with gout receiving GP follow-up. 2. To determine the feasibility of conducting a future randomised controlled trial to test the effectiveness of the app for patients with gout in primary care. Participants will be asked to test the self-management app for 3 months. Data will be collected from the participants and their GPs.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

⁃ Patients are eligible to be included in the study only if all the following criteria apply:

• Adults ≥18 years of age at screening

• Patients with a clinical diagnosis of gout

• Serum urate level \>360 µmol/L at inclusion

• Indication for urate lowering therapy assessed by medical doctor

• Having a smartphone/tablet

⁃ Patients are excluded from the study if any of the following criteria apply:

• Pregnant or breastfeeding

• Contraindication for urate lowering therapy

• Does not understand Norwegian language

• Major co-morbidities (e.g., malignancies, severe chronic kidney disease, severe mental disorders)

Locations
Other Locations
Norway
Diakonhjemmet Hospital
RECRUITING
Oslo
Contact Information
Primary
Fiona Aanesen, PhD
fiona.aanesen@diakonsyk.no
+47 22451500
Backup
Silje Søhus
silje.sohus@diakonsyk.no
Time Frame
Start Date: 2026-04
Estimated Completion Date: 2027-12
Participants
Target number of participants: 50
Treatments
Experimental: Self-management app
The patients will receive access to the self-management application 'MinUrinsyregikt' in addition to usual follow-up from their GP.
Related Therapeutic Areas
Sponsors
Collaborators: The Norwegian Rheumatism Association, REMEDY - Center for treatment of Rheumatic and Musculoskeletal Diseases, The Dam Foundation, Diakonhjemmet Hospital AS
Leads: Diakonhjemmet Hospital

This content was sourced from clinicaltrials.gov